Cargando…
Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1α–FNDC5 axis
Objective: Sarcopenia or frailty is common among patients with chronic kidney disease (CKD). The protein-bound uremic toxin indoxyl sulfate (IS) is associated with frailty. IS induces apoptosis and disruption of mitochondrial activity in skeletal muscle. However, the association of IS with anabolic...
Autores principales: | Hou, Yi-Chou, Liao, Min-Tser, Tsai, Kuo-Wang, Zheng, Cai-Mei, Chiu, Hui-Wen, Lu, Kuo-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637807/ https://www.ncbi.nlm.nih.gov/pubmed/37878003 http://dx.doi.org/10.18632/aging.205141 |
Ejemplares similares
-
Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
por: Cheng, Tong-Hong, et al.
Publicado: (2020) -
Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
por: Lu, Chien-Lin, et al.
Publicado: (2021) -
Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
por: Shyu, Jia-Fwu, et al.
Publicado: (2021) -
Assessment of PGC1α-FNDC5 Axis in Granulosa Cells of PCOS Mouse Model
por: Bakhshalizadeh, Shabnam, et al.
Publicado: (2018) -
Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease
por: Hou, Yi-Chou, et al.
Publicado: (2023)